Immunomodulatory effects of intravenous immunoglobulin G. 1991

J A Schifferli, and L Didierjean, and J H Saurat

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D009080 Mucocutaneous Lymph Node Syndrome An acute, febrile, mucocutaneous condition accompanied by swelling of cervical lymph nodes in infants and young children. The principal symptoms are fever, congestion of the ocular conjunctivae, reddening of the lips and oral cavity, protuberance of tongue papillae, and edema or erythema of the extremities. Kawasaki Disease,Lymph Node Syndrome, Mucocutaneous,Kawasaki Syndrome
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000276 Adjuvants, Immunologic Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. Immunoactivators,Immunoadjuvant,Immunoadjuvants,Immunologic Adjuvant,Immunopotentiator,Immunopotentiators,Immunostimulant,Immunostimulants,Adjuvant, Immunologic,Adjuvants, Immunological,Immunologic Adjuvants,Immunological Adjuvant,Adjuvant, Immunological,Immunological Adjuvants

Related Publications

J A Schifferli, and L Didierjean, and J H Saurat
December 2005, Clinical reviews in allergy & immunology,
J A Schifferli, and L Didierjean, and J H Saurat
December 2002, Immunology,
J A Schifferli, and L Didierjean, and J H Saurat
January 2015, Expert review of clinical immunology,
J A Schifferli, and L Didierjean, and J H Saurat
November 1989, Clinical immunology and immunopathology,
J A Schifferli, and L Didierjean, and J H Saurat
January 1998, Vojnosanitetski pregled,
J A Schifferli, and L Didierjean, and J H Saurat
April 2022, Expert review of neurotherapeutics,
J A Schifferli, and L Didierjean, and J H Saurat
June 2021, Scientific reports,
J A Schifferli, and L Didierjean, and J H Saurat
June 2012, Medicina clinica,
J A Schifferli, and L Didierjean, and J H Saurat
January 2006, Best practice & research. Clinical haematology,
J A Schifferli, and L Didierjean, and J H Saurat
October 2004, Presse medicale (Paris, France : 1983),
Copied contents to your clipboard!